In order to enforce the quality supervision over the biological vaccines (hereinafter referred to as vaccines), improve the quality assurance in vaccine production, circulation and inoculation and ensure safety and effectiveness of the vaccine, in accordance with the annual work plan, the State Food and Drug Administration (SFDA) and the Ministry of Health decided to jointly launch the supervision and examination program to the supervision of the vaccine production, circulation and inoculation and the implementation of relevant measures and recently issued a notice on the relevant issues.

This supervision and examination program is launched specially for the supervision enforcement of the local food and drug administrations and the health administrative departments in the vaccine production, circulation and inoculation, to learn about the actual situation of the supervision over the vaccine production, circulation and usage, specify the weakness and problems in the process, and deliberate measures enforcing the vaccine supervision. The program starts in June 2010.